PMC:7441777 / 1815-2089
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T10 | 176-184 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T34 | 98-102 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T35 | 116-119 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
52 | 110-114 | Gene | denotes | TF2b | Gene:2959 |
53 | 132-136 | Gene | denotes | RdRp | Gene:43740578 |
74 | 98-102 | Chemical | denotes | EGCG | MESH:C045651 |
81 | 176-184 | Disease | denotes | COVID-19 | MESH:C000657245 |
126 | 254-273 | Disease | denotes | Coronavirus disease | MESH:D018352 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20 | 64-185 | Sentence | denotes | Overall, our results suggest that EGCG, TF2a, TF2b, TF3 can inhibit RdRp and represent an effective therapy for COVID-19. |
T21 | 186-214 | Sentence | denotes | Communicated by Ramaswamy H. |
T22 | 215-220 | Sentence | denotes | Sarma |
T23 | 222-224 | Sentence | denotes | 1. |
T24 | 226-238 | Sentence | denotes | Introduction |